[No routine antibiotic prophylaxis necessary in endoscopic retrograde cholangiopancreatography]. 1997

P C van de Meeberg, and G P van Berge Henegouwen
Academisch Ziekenhuis, afd., Gastro-enterologie, Utrecht.

Acute cholangitis is a serious complication and cause of death in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP). Some centres have adopted a policy of administering antibiotics before every ERCP procedure. The results of a recent clinical trial failed to support this policy. Antibiotic prophylaxis should be restricted to patients expected to develop incomplete drainage of the bile duct and to endocarditis prophylaxis.

UI MeSH Term Description Entries
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D002760 Cholangiopancreatography, Endoscopic Retrograde Fiberoptic endoscopy designed for duodenal observation and cannulation of VATER'S AMPULLA, in order to visualize the pancreatic and biliary duct system by retrograde injection of contrast media. Endoscopic (Vater) papillotomy (SPHINCTEROTOMY, ENDOSCOPIC) may be performed during this procedure. ERCP,Endoscopic Retrograde Cholangiopancreatography,Retrograde Cholangiopancreatography, Endoscopic,Cholangiopancreatographies, Endoscopic Retrograde,Endoscopic Retrograde Cholangiopancreatographies,Retrograde Cholangiopancreatographies, Endoscopic
D002761 Cholangitis Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both. Cholangitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

P C van de Meeberg, and G P van Berge Henegouwen
February 1986, European journal of clinical microbiology,
P C van de Meeberg, and G P van Berge Henegouwen
February 1996, Gastroenterologie clinique et biologique,
P C van de Meeberg, and G P van Berge Henegouwen
June 1997, Annals of internal medicine,
P C van de Meeberg, and G P van Berge Henegouwen
February 1999, Alimentary pharmacology & therapeutics,
P C van de Meeberg, and G P van Berge Henegouwen
October 2010, The Cochrane database of systematic reviews,
P C van de Meeberg, and G P van Berge Henegouwen
November 1999, Endoscopy,
P C van de Meeberg, and G P van Berge Henegouwen
January 1993, Gastroenterologie clinique et biologique,
P C van de Meeberg, and G P van Berge Henegouwen
January 2005, International urology and nephrology,
Copied contents to your clipboard!